Your browser doesn't support javascript.
loading
Overexpression of p53 protein in Barrett's syndrome with malignant transformation.
Fléjou, J F; Potet, F; Muzeau, F; Le Pelletier, F; Fékété, F; Hénin, D.
Afiliação
  • Fléjou JF; Department of Pathology, Hôpital Beaujon, Clichy, France.
J Clin Pathol ; 46(4): 330-3, 1993 Apr.
Article em En | MEDLINE | ID: mdl-8496390
AIMS: To study the overexpression of p53 protein in Barrett's oesophagus with adenocarcinoma, and to correlate this expression with the pathological features of Barrett's syndrome. METHODS: Immunohistochemical staining was performed on frozen sections with a monoclonal antibody directed against wild type and mutated p53 protein (Pab 1801). Eleven cases of Barrett's adenocarcinoma were studied, seven of which had extensive sampling of benign Barrett's mucosa. RESULTS: Eight of 11 adenocarcinomas overexpressed the p53 protein. Both early and advanced tumours were positive. In Barrett's mucosa around the p53 positive tumours, high grade dysplasia was positive; low grade dysplasia and non-dysplastic mucosa were negative. CONCLUSIONS: P53 gene mutation with ensuing p53 protein overexpression is a common feature of Barrett's adenocarcinoma, both at early and advanced stages. This mutation appears as a relatively late event during the neoplastic transformation of Barrett's oesophagus.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esôfago de Barrett / Neoplasias Esofágicas / Adenocarcinoma / Proteína Supressora de Tumor p53 Limite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: J Clin Pathol Ano de publicação: 1993 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esôfago de Barrett / Neoplasias Esofágicas / Adenocarcinoma / Proteína Supressora de Tumor p53 Limite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: J Clin Pathol Ano de publicação: 1993 Tipo de documento: Article País de afiliação: França